Role of dietary phenols in mitigating microglia-mediated neuroinflammation

NeuroMolecular Medicine

Volumn 18, Issue 3, 2016, Pages 453-464

  Rangarajan, Parakalan ^a   Karthikeyan, Aparna ^a   Dheen, S T ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

CNS; Curcumin; Luteolin; Microglia; Neuroinflammation; Quercetin; Resveratrol

Indexed keywords

CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; LUTEOLIN; MITOGEN ACTIVATED PROTEIN KINASE; PHENOL DERIVATIVE; QUERCETIN; RESVERATROL; STAT PROTEIN; STILBENE; ANTIINFLAMMATORY AGENT;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; AUTISM; BEHAVIOR DISORDER; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DIET; DIET SUPPLEMENTATION; DRUG TARGETING; GLIOMA; HUMAN; HUNTINGTON CHOREA; MICROGLIA; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TRAUMATIC BRAIN INJURY; ANIMAL; DEGENERATIVE DISEASE; DIETARY SUPPLEMENT; INFLAMMATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DIETARY SUPPLEMENTS; HUMANS; INFLAMMATION; MICROGLIA; NEURODEGENERATIVE DISEASES; PHENOLS;

EID: 84979974242     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-016-8430-x     Document Type: Review

References (129)

1. Ahmad, A., Khan, M. M., Hoda, M. N., Raza, S. S., Khan, M. B., Javed, H., et al. (2011). Quercetin protects against oxidative stress associated damages in a rat model of transient focal cerebral ischemia and reperfusion. Neurochemical Research, 36(8), 1360–1371.
2. Albright, A. V., & González-Scarano, F. (2004). Microarray analysis of activated mixed glial (microglia) and monocyte-derived macrophage gene expression. Journal of Neuroimmunology, 157(1), 27–38.
3. Amri, A., Chaumeil, J. C., Sfar, S., & Charrueau, C. (2012). Administration of resveratrol: what formulation solutions to bioavailability limitations? Journal of Controlled Release, 158(2), 182–193.
4. Bagli, E., Stefaniotou, M., Morbidelli, L., Ziche, M., Psillas, K., Murphy, C., et al. (2004). Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3′-kinase activity. Cancer Research, 64(21), 7936–7946.
5. Bambini-Junior, V., Zanatta, G., Nunes, G. D. F., de Melo, G. M., Michels, M., Fontes-Dutra, M., et al. (2014). Resveratrol prevents social deficits in animal model of autism induced by valproic acid. Neuroscience Letters, 583, 176–181.
6. Bhandari, R., & Kuhad, A. (2015). Neuropsychopharmacotherapeutic efficacy of curcumin in experimental paradigm of autism spectrum disorders. Life Sciences, 141, 156–169.
7. Bisht, K., Wagner, K.-H., & Bulmer, A. C. (2010). Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto-and DNA-protective dietary compounds. Toxicology, 278(1), 88–100.
8. Bournival, J., Plouffe, M., Renaud, J., Provencher, C., & Martinoli, M.-G. (2012). Quercetin and Sesamin Protect Dopaminergic Cells from MPP. Oxidative medicine and cellular longevity, 2012.
9. Burton, M. D., Rytych, J. L., Amin, R., & Johnson, R. W. (2015). Dietary luteolin reduces pro-inflammatory microglia in the brain of senescent mice. Rejuvenation Research(ja).
10. Busch, C., Burkard, M., Leischner, C., Lauer, U. M., Frank, J., & Venturelli, S. (2015). Epigenetic activities of flavonoids in the prevention and treatment of cancer. Clinical epigenetics, 7(1), 1.
11. Butovsky, O., Ziv, Y., Schwartz, A., Landa, G., Talpalar, A. E., Pluchino, S., et al. (2006). Microglia activated by IL-4 or IFN-γ differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Molecular and Cellular Neuroscience, 31(1), 149–160.
12. Capiralla, H., Vingtdeux, V., Zhao, H., Sankowski, R., Al-Abed, Y., Davies, P., et al. (2012). Resveratrol mitigates lipopolysaccharide-and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade. Journal of Neurochemistry, 120(3), 461–472.
13. Chakraborty, J., Singh, R., Dutta, D., Naskar, A., Rajamma, U., & Mohanakumar, K. P. (2014). Quercetin Improves Behavioral Deficiencies, Restores Astrocytes and Microglia, and Reduces Serotonin Metabolism in 3-Nitropropionic Acid-Induced Rat Model of Huntington’s Disease. CNS Neuroscience & Therapeutics, 20(1), 10–19.
14. Chan, A., Seguin, R., Magnus, T., Papadimitriou, C., Toyka, K. V., Antel, J. P., et al. (2003). Phagocytosis of apoptotic inflammatory cells by microglia and its therapeutic implications: termination of CNS autoimmune inflammation and modulation by interferon-beta. Glia, 43(3), 231–242.
15. Chang, C. Y., Choi, D.-K., Lee, D. K., Hong, Y. J., & Park, E. J. (2013). Resveratrol confers protection against rotenone-induced neurotoxicity by modulating myeloperoxidase levels in glial cells. PLoS ONE, 8(4), e60654.
16. Chen, J.-C., Ho, F.-M., Chao, P.-D. L., Chen, C.-P., Jeng, K.-C. G., Hsu, H.-B., et al. (2005). Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IκB kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia. European Journal of Pharmacology, 521(1), 9–20.
17. Cheng, A.-C., Huang, T.-C., Lai, C.-S., & Pan, M.-H. (2005). Induction of apoptosis by luteolin through cleavage of Bcl-2 family in human leukemia HL-60 cells. European Journal of Pharmacology, 509(1), 1–10.
18. Cheng, K. K., Yeung, C. F., Ho, S. W., Chow, S. F., Chow, A. H., & Baum, L. (2013). Highly stabilized curcumin nanoparticles tested in an in vitro blood–brain barrier model and in Alzheimer’s disease Tg2576 mice. The AAPS journal, 15(2), 324–336.
19. Cherry, J. D., Olschowka, J. A., & O’Banion, M. K. (2014). Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation, 11(1), 98.
20. Choi, D. K., Koppula, S., & Suk, K. (2011). Inhibitors of microglial neurotoxicity: focus on natural products. Molecules, 16(2), 1021–1043.
21. Chun-Fu, W., Jing-Yu, Y., Fang, W., & Xiao-Xiao, W. (2013). Resveratrol: botanical origin, pharmacological activity and applications. Chinese Journal of Natural Medicines, 11(1), 1–15.
22. Chung, S. Y., & Han, S. H. (2003). Melatonin attenuates kainic acid-induced hippocampal neurodegeneration and oxidative stress through microglial inhibition. Journal of Pineal Research, 34(2), 95–102.
23. Cianciulli, A., Dragone, T., Calvello, R., Porro, C., Trotta, T., Lofrumento, D. D., et al. (2015). IL-10 plays a pivotal role in anti-inflammatory effects of resveratrol in activated microglia cells. International Immunopharmacology, 24(2), 369–376.
24. Clark, D., Tuor, U. I., Thompson, R., Institoris, A., Kulynych, A., Zhang, X., et al. (2012). Protection against recurrent stroke with resveratrol: endothelial protection. PLoS ONE, 7(10), e47792.
25. Crain, J. M., Nikodemova, M., & Watters, J. J. (2013). Microglia express distinct M1 and M2 phenotypic markers in the postnatal and adult central nervous system in male and female mice. Journal of Neuroscience Research, 91(9), 1143–1151.
26. Cullheim, S., & Thams, S. (2007). The microglial networks of the brain and their role in neuronal network plasticity after lesion. Brain Research Reviews, 55(1), 89–96.
27. Dhawan, S., Kapil, R., & Singh, B. (2011). Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery. Journal of Pharmacy and Pharmacology, 63(3), 342–351.
28. Dheen, S. T., Jun, Y., Yan, Z., Tay, S. S., & Ang Ling, E. (2005). Retinoic acid inhibits expression of TNF-α and iNOS in activated rat microglia. Glia, 50(1), 21–31.
29. Dirscherl, K., Karlstetter, M., Ebert, S., Kraus, D., Hlawatsch, J., Walczak, Y., et al. (2010). Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype. J Neuroinflammation, 7(3), 1742–2094.
30. Dohare, P., Garg, P., Jain, V., Nath, C., & Ray, M. (2008). Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat. Behavioural Brain Research, 193(2), 289–297.
31. Dohi, K., Ohtaki, H., Nakamachi, T., Yofu, S., Satoh, K., Miyamoto, K., et al. (2010). Gp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury. J Neuroinflammation, 7(1), 41.
32. Dragone, T., Cianciulli, A., Calvello, R., Porro, C., Trotta, T., & Panaro, M. A. (2014). Resveratrol counteracts lipopolysaccharide-mediated microglial inflammation by modulating a SOCS-1 dependent signaling pathway. Toxicology in Vitro, 28(6), 1126–1135.
33. Frémont, L. (2000). Biological effects of resveratrol. Life Sciences, 66(8), 663–673.
34. Garcia-Alloza, M., Borrelli, L., Rozkalne, A., Hyman, B., & Bacskai, B. (2007). Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. Journal of Neurochemistry, 102(4), 1095–1104.
35. Gómez-Nicola, D., Fransen, N. L., Suzzi, S., & Perry, V. H. (2013). Regulation of microglial proliferation during chronic neurodegeneration. The Journal of Neuroscience, 33(6), 2481–2493.
36. Graeber, M. B., Scheithauer, B. W., & Kreutzberg, G. W. (2002). Microglia in brain tumors. Glia, 40(2), 252–259.
37. Guardia, T., Rotelli, A. E., Juarez, A. O., & Pelzer, L. E. (2001). Anti-inflammatory properties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Il farmaco, 56(9), 683–687.
38. Gupta, S. C., Patchva, S., & Aggarwal, B. B. (2013). Therapeutic roles of curcumin: lessons learned from clinical trials. The AAPS journal, 15(1), 195–218.
39. Gupta, S. C., Prasad, S., Kim, J. H., Patchva, S., Webb, L. J., Priyadarsini, I. K., et al. (2011). Multitargeting by curcumin as revealed by molecular interaction studies. Natural product reports, 28(12), 1937–1955.
40. Hanisch, U. K. (2002). Microglia as a source and target of cytokines. Glia, 40(2), 140–155.
41. Hanisch, U.-K., & Kettenmann, H. (2007). Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nature Neuroscience, 10(11), 1387–1394.
42. He, L.-F., Chen, H.-J., Qian, L.-H., Chen, G.-Y., & Buzby, J. S. (2010). Curcumin protects pre-oligodendrocytes from activated microglia in vitro and in vivo. Brain Research, 1339, 60–69.
43. Hickman, S. E., Kingery, N. D., Ohsumi, T. K., Borowsky, M. L., Wang, L.-C., Means, T. K., et al. (2013). The microglial sensome revealed by direct RNA sequencing. Nature Neuroscience, 16(12), 1896–1905.
44. Ho, L., Ferruzzi, M. G., Janle, E. M., Wang, J., Gong, B., Chen, T.-Y., et al. (2013). Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer’s disease. The FASEB Journal, 27(2), 769–781.
45. Huo, Y., Rangarajan, P., Ling, E.-A., & Dheen, S. T. (2011). Dexamethasone inhibits the Nox-dependent ROS production via suppression of MKP-1-dependent MAPK pathways in activated microglia. BMC neuroscience, 12(1), 49.
46. Ishisaka, A., Ichikawa, S., Sakakibara, H., Piskula, M. K., Nakamura, T., Kato, Y., et al. (2011). Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats. Free Radical Biology and Medicine, 51(7), 1329–1336.
47. Jang, S., Dilger, R. N., & Johnson, R. W. (2010). Luteolin inhibits microglia and alters hippocampal-dependent spatial working memory in aged mice. The Journal of nutrition, 140(10), 1892–1898.
48. Jang, S., Kelley, K. W., & Johnson, R. W. (2008). Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1. Proceedings of the National Academy of Sciences, 105(21), 7534–7539.
49. Jasiński, M., Jasińska, L., & Ogrodowczyk, M. (2013). Resveratrol in prostate diseases-a short review. Central European journal of 0075rology, 66(2)
50. Jin, C.-Y., Lee, J.-D., Park, C., Choi, Y-h, & Kim, G.-Y. (2007). Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia. Acta Pharmacologica Sinica, 28(10), 1645–1651.
51. Jin, F., Wu, Q., Lu, Y.-F., Gong, Q.-H., & Shi, J.-S. (2008). Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson’s disease in rats. European Journal of Pharmacology, 600(1), 78–82.
52. Joseph, J. A., Fisher, D. R., Cheng, V., Rimando, A. M., & Shukitt-Hale, B. (2008). Cellular and behavioral effects of stilbene resveratrol analogues: implications for reducing the deleterious effects of aging. Journal of Agricultural and Food Chemistry, 56(22), 10544–10551.
53. Jung, K. K., Lee, H. S., Cho, J. Y., Shin, W. C., Rhee, M. H., Kim, T. G., et al. (2006). Inhibitory effect of curcumin on nitric oxide production from lipopolysaccharide-activated primary microglia. Life Sciences, 79(21), 2022–2031.
54. Kao, T.-K., Ou, Y.-C., Lin, S.-Y., Pan, H.-C., Song, P.-J., Raung, S.-L., et al. (2011). Luteolin inhibits cytokine expression in endotoxin/cytokine-stimulated microglia. The Journal of nutritional biochemistry, 22(7), 612–624.
55. Kao, T.-K., Ou, Y.-C., Raung, S.-L., Lai, C.-Y., Liao, S.-L., & Chen, C.-J. (2010). Inhibition of nitric oxide production by quercetin in endotoxin/cytokine-stimulated microglia. Life Sciences, 86(9), 315–321.
56. Karlstetter, M., Lippe, E., Walczak, Y., Moehle, C., Aslanidis, A., Mirza, M., et al. (2011). Curcumin is a potent modulator of microglial gene expression and migration. J Neuroinflammation, 8, 125.
57. Karuppagounder, S. S., Pinto, J. T., Xu, H., Chen, H.-L., Beal, M. F., & Gibson, G. E. (2009). Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer’s disease. Neurochemistry International, 54(2), 111–118.
58. Kaushal, V., & Schlichter, L. C. (2008). Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. The Journal of Neuroscience, 28(9), 2221–2230.
59. Kelso, M. L., Scheff, N. N., Scheff, S. W., & Pauly, J. R. (2011). Melatonin and minocycline for combinatorial therapy to improve functional and histopathological deficits following traumatic brain injury. Neuroscience Letters, 488(1), 60–64.
60. Kettenmann, H., Kirchhoff, F., & Verkhratsky, A. (2013). Microglia: new roles for the synaptic stripper. Neuron, 77(1), 10–18.
61. Kim, H. J., Lee, W., & Yun, J. M. (2014). Luteolin Inhibits Hyperglycemia-Induced Proinflammatory Cytokine Production and Its Epigenetic Mechanism in Human Monocytes. Phytotherapy Research, 28(9), 1383–1391.
62. Kim, H. Y., Park, E. J., Joe, E.-H., & Jou, I. (2003). Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia. The Journal of Immunology, 171(11), 6072–6079.
63. Koedel, U., & Pfister, H. W. (1999). Oxidative stress in bacterial meningitis. Brain Pathology, 9(1), 57–67.
64. Kumar, A., Alvarez-Croda, D.-M., Stoica, B. A., Faden, A. I., & Loane, D. J. (2015). Microglial/macrophage polarization dynamics following traumatic brain injury. Journal of neurotrauma.
65. Labinskyy, N., Csiszar, A., Veress, G., Stef, G., Pacher, P., Oroszi, G., et al. (2006). Vascular dysfunction in aging: potential effects of resveratrol, an anti-inflammatory phytoestrogen. Current Medicinal Chemistry, 13(9), 989.
66. Lalancette-Hébert, M., Gowing, G., Simard, A., Weng, Y. C., & Kriz, J. (2007). Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. The Journal of Neuroscience, 27(10), 2596–2605.
67. Lee, K.-H., Park, E., Lee, H.-J., Kim, M.-O., Cha, Y.-J., Kim, J.-M., et al. (2011). Effects of daily quercetin-rich supplementation on cardiometabolic risks in male smokers. Nutrition research and practice, 5(1), 28–33.
68. Li, W., & Graeber, M. B. (2012). The molecular profile of microglia under the influence of glioma. Neuro-oncology, nos116.
69. Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001). The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. The Journal of Neuroscience, 21(21), 8370–8377.
70. Lin, L.-F., Chiu, S.-P., Wu, M.-J., Chen, P.-Y., & Yen, J.-H. (2012). Luteolin induces microRNA-132 expression and modulates neurite outgrowth in PC12 cells. PLoS ONE, 7(8), e43304.
71. Liu, Z.-J., Liu, W., Liu, L., Xiao, C., Wang, Y., & Jiao, J.-S. (2013). Curcumin protects neuron against cerebral ischemia-induced inflammation through improving PPAR-gamma function. Evidence-Based Complementary and Alternative Medicine, 2013.
72. Lopez-Lazaro, M. (2009). Distribution and biological activities of the flavonoid luteolin. Mini reviews in medicinal chemistry, 9(1), 31–59.
73. Lorenz, P., Roychowdhury, S., Engelmann, M., Wolf, G., & Horn, T. F. (2003). Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: effect on nitrosative and oxidative stress derived from microglial cells. Nitric Oxide, 9(2), 64–76.
74. Maheshwari, R. K., Singh, A. K., Gaddipati, J., & Srimal, R. C. (2006). Multiple biological activities of curcumin: a short review. Life Sciences, 78(18), 2081–2087.
75. Majumdar, A., Cruz, D., Asamoah, N., Buxbaum, A., Sohar, I., Lobel, P., et al. (2007). Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils. Molecular Biology of the Cell, 18(4), 1490–1496.
76. Mokni, M., Elkahoui, S., Limam, F., Amri, M., & Aouani, E. (2007). Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochemical Research, 32(6), 981–987.
77. Moran, L., Duke, D., Turkheimer, F., Banati, R., & Graeber, M. (2004). Towards a transcriptome definition of microglial cells. Neurogenetics, 5(2), 95–108.
78. Murakami, A., Ashida, H., & Terao, J. (2008). Multitargeted cancer prevention by quercetin. Cancer Letters, 269(2), 315–325.
79. Muthian, G., & Bright, J. J. (2004). Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte. Journal of Clinical Immunology, 24(5), 542–552.
80. Nayak, D., Huo, Y., Kwang, W., Pushparaj, P., Kumar, S., Ling, E.-A., et al. (2010). Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia. Neuroscience, 166(1), 132–144.
81. Nazari, Q. A., Takada-Takatori, Y., Hashimoto, T., Imaizumi, A., Izumi, Y., Akaike, A., et al. (2014). Potential protective effect of highly bioavailable curcumin on an oxidative stress model induced by microinjection of sodium nitroprusside in mice brain. Food & function, 5(5), 984–989.
82. Nichols, J. A., & Katiyar, S. K. (2010). Skin photoprotection by natural polyphenols: anti-inflammatory, antioxidant and DNA repair mechanisms. Archives of Dermatological Research, 302(2), 71–83.
83. Parakalan, R., Jiang, B., Nimmi, B., Janani, M., Jayapal, M., Lu, J., et al. (2012). Transcriptome analysis of amoeboid and ramified microglia isolated from the corpus callosum of rat brain. BMC neuroscience, 13(1), 1.
84. Park, E., Kim, D. K., & Chun, H. S. (2012). Resveratrol inhibits lipopolysaccharide-induced phagocytotic activity in BV2 cells. Journal of the Korean Society for Applied Biological Chemistry, 55(6), 803–807.
85. Perry, M. C., Demeule, M., Regina, A., Moumdjian, R., & Beliveau, R. (2010a). Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts. Molecular Nutrition & Food Research, 54(8), 1192–1201.
86. Perry, V. H., Nicoll, J. A., & Holmes, C. (2010b). Microglia in neurodegenerative disease. Nature Reviews Neurology, 6(4), 193–201.
87. Persidsky, Y., & Gendelman, H. E. (2003). Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection. Journal of Leukocyte Biology, 74(5), 691–701.
88. Piantadosi, C. A., Withers, C. M., Bartz, R. R., MacGarvey, N. C., Fu, P., Sweeney, T. E., et al. (2011). Heme oxygenase-1 couples activation of mitochondrial biogenesis to anti-inflammatory cytokine expression. Journal of Biological Chemistry, 286(18), 16374–16385.
89. Ramlackhansingh, A. F., Brooks, D. J., Greenwood, R. J., Bose, S. K., Turkheimer, F. E., Kinnunen, K. M., et al. (2011). Inflammation after trauma: microglial activation and traumatic brain injury. Annals of neurology, 70(3), 374–383.
90. Rangarajan, P., Eng-Ang, L., & Thameem Dheen, S. (2013). Potential drugs targeting microglia: current knowledge and future prospects. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 12(6), 799-806.
91. Rayan, N., Baby, N., Pitchai, D., Indraswari, F., Ling, E., Lu, J., et al. (2010). Costunolide inhibits proinflammatory cytokines and iNOS in activated murine BV2 microglia. Frontiers in bioscience (Elite edition), 3, 1079–1091.
92. Reichard, J. F., Motz, G. T., & Puga, A. (2007). Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1. Nucleic Acids Research, 35(21), 7074–7086.
93. Rezai-Zadeh, K., Ehrhart, J., Bai, Y., Sanberg, P. R., Bickford, P., Tan, J., et al. (2008). Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression. J Neuroinflammation, 5, 41.
94. Rinwa, P., & Kumar, A. (2013). Quercetin suppress microglial neuroinflammatory response and induce antidepressent-like effect in olfactory bulbectomized rats. Neuroscience, 255, 86–98.
95. Sabogal-Guáqueta, A. M., Muñoz-Manco, J. I., Ramírez-Pineda, J. R., Lamprea-Rodriguez, M., Osorio, E., & Cardona-Gómez, G. P. (2015). The flavonoid quercetin ameliorates Alzheimer’s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer’s disease model mice. Neuropharmacology, 93, 134–145.
96. Saijo, K., & Glass, C. K. (2011). Microglial cell origin and phenotypes in health and disease. Nature Reviews Immunology, 11(11), 775–787.
97. Samini, F., Samarghandian, S., Borji, A., & Mohammadi, G. (2013). Curcumin pretreatment attenuates brain lesion size and improves neurological function following traumatic brain injury in the rat. Pharmacology, Biochemistry and Behavior, 110, 238–244.
98. Satoh, J.-I., Asahina, N., Kitano, S., & Kino, Y. (2014). A comprehensive profile of ChIP-Seq-Based PU. 1/Spi1 target genes in microglia. Gene regulation and systems biology, 8, 127.
99. Sawmiller, D., Li, S., Shahaduzzaman, M., Smith, A. J., Obregon, D., Giunta, B., et al. (2014). Luteolin reduces Alzheimer’s disease pathologies induced by traumatic brain injury. International Journal of Molecular Sciences, 15(1), 895–904.
100. Schmitt, E., Hoehn, P., Huels, C., Goedert, S., Palm, N., Rüde, E., et al. (1994). T helper type 1 development of naive CD4 + T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited by transforming growth factor-β. European Journal of Immunology, 24(4), 793–798.
101. Schraufstätter, E., & Bernt, H. (1949). Antibacterial action of curcumin and related compounds. Nature, 164, 456–457.
102. Sönmez, Ü., Sönmez, A., Erbil, G., Tekmen, I., & Baykara, B. (2007). Neuroprotective effects of resveratrol against traumatic brain injury in immature rats. Neuroscience Letters, 420(2), 133–137.
103. Soriano, F. X., Léveillé, F., Papadia, S., Higgins, L. G., Varley, J., Baxter, P., et al. (2008). Induction of sulfiredoxin expression and reduction of peroxiredoxin hyperoxidation by the neuroprotective Nrf2 activator 3H–1, 2-dithiole-3-thione. Journal of Neurochemistry, 107(2), 533–543.
104. Stence, N., Waite, M., & Dailey, M. E. (2001). Dynamics of microglial activation: a confocal time-lapse analysis in hippocampal slices. Glia, 33(3), 256–266.
105. Streit, W. J. (2006). Microglial senescence: does the brain’s immune system have an expiration date? Trends in Neurosciences, 29(9), 506–510.
106. Sun, G. Y., Chen, Z., Jasmer, K. J., Chuang, D. Y., Gu, Z., Hannink, M., et al. (2015). Quercetin attenuates inflammatory responses in BV-2 microglial cells: role of MAPKs on the Nrf2 pathway and induction of heme oxygenase-1. PLoS ONE, 10(10), e0141509.
107. Sun, D., Zhuang, X., Xiang, X., Liu, Y., Zhang, S., Liu, C., et al. (2010). A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Molecular Therapy, 18(9), 1606–1614.
108. Suzuki, K., Sugihara, G., Ouchi, Y., Nakamura, K., Futatsubashi, M., Takebayashi, K., et al. (2013). Microglial activation in young adults with autism spectrum disorder. JAMA psychiatry, 70(1), 49–58.
109. Takano, T. (2015). Role of microglia in autism: recent advances. Developmental Neuroscience, 37(3), 195–202.
110. Taliou, A., Zintzaras, E., Lykouras, L., & Francis, K. (2013). An open-label pilot study of a formulation containing the anti-inflammatory flavonoid luteolin and its effects on behavior in children with autism spectrum disorders. Clinical Therapeutics, 35(5), 592–602.
111. Taylor, R. A., & Sansing, L. H. (2013). Microglial responses after ischemic stroke and intracerebral hemorrhage. Clinical and Developmental Immunology, 2013.
112. Tchantchou, F., Lacor, P. N., Cao, Z., Lao, L., Hou, Y., Cui, C., et al. (2009). Stimulation of neurogenesis and synaptogenesis by bilobalide and quercetin via common final pathway in hippocampal neurons. Journal of Alzheimer’s Disease, 18(4), 787–798.
113. Teiten, M. H., Dicato, M., & Diederich, M. (2013). Curcumin as a regulator of epigenetic events. Molecular Nutrition & Food Research, 57(9), 1619–1629.
114. Thameem Dheen, S., Kaur, C., & Ling, E.-A. (2007). Microglial activation and its implications in the brain diseases. Current Medicinal Chemistry, 14(11), 1189–1197.
115. Thored, P., Heldmann, U., Gomes-Leal, W., Gisler, R., Darsalia, V., Taneera, J., et al. (2009). Long-term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke. Glia, 57(8), 835–849.
116. Tsilioni, I., Taliou, A., & FrancisK, Theoharides T. (2015). Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6. Translational Psychiatry, 5(9), e647.
117. Venturelli, S., Berger, A., Böcker, A., Busch, C., Weiland, T., Noor, S., et al. (2013). Resveratrol as a pan-HDAC inhibitor alters the acetylation status of histone proteins in human-derived hepatoblastoma cells. PLoS ONE, 8(8), e73097.
118. Vidak, M., Rozman, D., & Komel, R. (2015). Effects of Flavonoids from Food and Dietary Supplements on Glial and Glioblastoma Multiforme Cells. Molecules, 20(10), 19406–19432.
119. Walker, D. G., & Lue, L.-F. (2015). Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains. Alzheimer’s Research & Therapy, 7(1), 1–9.
120. Wang, G., Zhang, J., Hu, X., Zhang, L., Mao, L., Jiang, X., et al. (2013). Microglia/macrophage polarization dynamics in white matter after traumatic brain injury. Journal of Cerebral Blood Flow and Metabolism, 33(12), 1864–1874.
121. Wilkinson, B. L., & Landreth, G. E. (2006). The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer’s disease. J Neuroinflammation, 3(1), 30.
122. Wu, A., Ying, Z., & Gomez-Pinilla, F. (2006). Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition. Experimental Neurology, 197(2), 309–317.
123. Xu, J., & Drew, P. D. (2006). 9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes. Journal of Neuroimmunology, 171(1), 135–144.
124. Youdim, K. A., Qaiser, M. Z., Begley, D. J., Rice-Evans, C. A., & Abbott, N. J. (2004). Flavonoid permeability across an in situ model of the blood–brain barrier. Free Radical Biology and Medicine, 36(5), 592–604.
125. Zhang, Y., Yi, B., Ma, J., Zhang, L., Zhang, H., Yang, Y., et al. (2015). Quercetin promotes neuronal and behavioral recovery by suppressing inflammatory response and apoptosis in a rat model of intracerebral hemorrhage. Neurochemical Research, 40(1), 195–203.
126. Zhao, J., Yu, S., Zheng, W., Feng, G., Luo, G., Wang, L., et al. (2010). Curcumin improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Neurochemical Research, 35(3), 374–379.
127. Zhu, L.-H., Bi, W., Qi, R.-B., Wang, H.-D., & Lu, D.-X. (2011). Luteolin inhibits microglial inflammation and improves neuron survival against inflammation. International Journal of Neuroscience, 121(6), 329–336.
128. Zhu, H., Bian, C., Yuan, J., Chu, W., Xiang, X., Chen, F., et al. (2014). Curcumin attenuates acute inflammatory injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway in experimental traumatic brain injury. J Neuroinflammation, 11(59), 1186.
129. Zou, L., Liu, W., Liu, C., Xiao, H., & McClements, D. J. (2015). Utilizing food matrix effects to enhance nutraceutical bioavailability: increase of curcumin bioaccessibility using excipient emulsions. Journal of Agricultural and Food Chemistry, 63(7), 2052–2062.